Sevoflurane has long been a cornerstone of pediatric anesthesia, allowing millions of children to undergo necessary surgical procedures safely and without pain each year. Despite its widespread and effective use, a shadow of concern has emerged from preclinical research, where animal studies have
Intraventricular hemorrhage, a form of bleeding within the brain's delicate ventricles, represents one of the most significant threats to the long-term health and neurodevelopment of preterm infants. For decades, the standard of care has been largely reactive, identifying brain bleeds only after
The continued access to virtual medical care for millions of American seniors hangs precariously in the balance, subject to a legislative cycle of temporary extensions that introduces profound instability into the nation's healthcare system. Responding to this critical uncertainty, the American
The blueprint for a life-saving drug can often be found in the intricate, three-dimensional architecture of a single protein, yet viewing this structure with perfect clarity has remained a persistent challenge for modern science. For pharmaceutical researchers, this microscopic world is the
As a leading expert in biopharma innovation and research, Ivan Kairatov offers a unique perspective on the evolving landscape of cancer treatment. His work focuses on translating complex clinical trial data into practical advancements that reshape patient care. Today, we delve into the RECIPROCAL
The 44 new drugs that gained approval from the FDA's Center for Drug Evaluation and Research in 2025 represented far more than a simple numerical milestone; they collectively heralded a fundamental paradigm shift in the landscape of therapeutic development. This pivotal year was defined not by the
